Shakespeare Monofilament acquisition secures £5.92m asset-based funding package

Arbuthnot Banking Group

Arbuthnot Commercial Asset Based Lending has provided a £5.92 million asset-based lending facility to support Nova Capital Management’s acquisition of Shakespeare Monofilament UK, forming part of Nova’s wider purchase of the Shakespeare businesses in the UK and United States.

The transaction brings together several forms of secured financing, reflecting the range of assets available within Shakespeare Monofilament UK and the funding requirements associated with a change of ownership. The package comprises £2.5 million of confidential invoice discounting, a £1.5 million inventory revolver, £222,000 secured against plant and machinery, and a £1.7 million property term loan.

This diversified funding structure reduces reliance on a single source of borrowing and gives the acquired business access to capital across different parts of its asset base. Receivables and inventory provide working capital support, while the machinery and property elements introduce longer-term funding against fixed assets. The combination is designed to provide greater flexibility as the company enters its next phase under Nova Capital Management.

Shakespeare Monofilament UK is based in Fleetwood, Lancashire, and traces its history to 1897. The manufacturer operates across three principal product areas covering performance monofilaments, engineered nylons, and conductive fibres, polymers and filaments. Its manufacturing focus places the business within specialist engineered materials markets where production assets, inventory requirements and customer receivables can all play an important role in determining the most appropriate financing structure.

The £5.92 million facility is also the first transaction between Arbuthnot Commercial Asset Based Lending and Nova Capital Management. Its significance extends beyond the establishment of a new lending relationship, as the UK acquisition formed part of a broader cross-border transaction involving the simultaneous purchase of Shakespeare Company in the United States.

Arbuthnot Banking Group PLC (LON:ARBB), operating as Arbuthnot Latham, offers private and commercial banking products and services in the United Kingdom. Established in 1833, Arbuthnot Banking is headquartered in London, United Kingdom.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Arbuthnot provides growth funding to Aaron Engineering Group

Arbuthnot Commercial Asset Based Lending has provided Aaron Engineering Group with increased working capital facilities to support expansion across...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Arbuthnot Latham increases semiconductor exposure as AI investment supports market opportunities

Arbuthnot Latham continues to see opportunities in AI and semiconductor investment, increasing its technology exposure while adding to high-yield...

Arbuthnot Banking Group Raises 2026 Profit Expectations After Lending and Wealth Growth

Arbuthnot Banking Group raises its 2026 profit expectations after customer lending increases 12%, specialist lending grows 26% and wealth...

Sigma GRP secures new funding to accelerate acquisitions and expansion

Sigma GRP secures new asset-based lending from Arbuthnot Commercial to support acquisitions and accelerate expansion, building on double-digit growth...

Autumn Budget 2026: Key tax changes for wealthy individuals, investors and businesses

The Autumn Budget 2026 brings higher taxes on savings and property income, reduced business disposal relief and a new...

Search